trimetazidine has been researched along with Electrocardiogram QT Prolonged in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahangarpour, A; Badavi, M; Dianat, M; Mard, SA; Ramezani-Aliakbari, F | 1 |
Mansur, AJ | 1 |
Balenović, D; Baotić, I; Cavrić, G; Horvat, I; Pocanić, D; Prkacin, I | 1 |
3 other study(ies) available for trimetazidine and Electrocardiogram QT Prolonged
Article | Year |
---|---|
The Effects of Trimetazidine on QT-interval Prolongation and Cardiac Hypertrophy in Diabetic Rats.
Topics: Animals; Cardiomegaly; Catalase; Diabetes Complications; Diabetes Mellitus, Experimental; Echocardiography; Glutathione Peroxidase; Hemodynamics; Long QT Syndrome; Male; Protective Agents; Random Allocation; Rats, Sprague-Dawley; Reproducibility of Results; Superoxide Dismutase; Time Factors; Trimetazidine | 2019 |
Cardiac Effects of Trimetazidine in Diabetic Rats.
Topics: Animals; Cardiomegaly; Diabetes Mellitus, Experimental; Heart; Long QT Syndrome; Rats; Trimetazidine | 2019 |
[The effects of trimetazidine on QT-interval prolongation in patients with chronic kidney disease stage III-IV (predialysis CRD)].
Topics: Aged; Death, Sudden, Cardiac; Female; Humans; Long QT Syndrome; Male; Renal Insufficiency, Chronic; Trimetazidine; Vasodilator Agents | 2012 |